Opaleye Management Inc. Protara Therapeutics, Inc. Transaction History
Opaleye Management Inc.
- $390 Million
- Q2 2024
A detailed history of Opaleye Management Inc. transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Opaleye Management Inc. holds 2,304,262 shares of TARA stock, worth $4.29 Million. This represents 1.23% of its overall portfolio holdings.
Number of Shares
2,304,262
Previous 2,692,594
14.42%
Holding current value
$4.29 Million
Previous $10.8 Million
55.62%
% of portfolio
1.23%
Previous 2.63%
Shares
8 transactions
Others Institutions Holding TARA
# of Institutions
43Shares Held
10.4MCall Options Held
25KPut Options Held
12.7K-
Ra Capital Management, L.P. Boston, MA1.9MShares$3.53 Million0.06% of portfolio
-
Stem Point Capital LP New York, NY984KShares$1.83 Million0.6% of portfolio
-
Boxer Capital, LLC San Diego, CA812KShares$1.51 Million0.09% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il665KShares$1.24 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY537KShares$998,5070.01% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $21M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...